Arlene Morris

Chief Executive Officer at Willow Advisors LLC

Arlene Morris

Arlene Morris

Chief Executive Officer at Willow Advisors LLC

Overview
Career Highlights

Willow Advisors LLC
Syndax Pharmaceuticals, Inc.
Affymax, Inc.

RelSci Relationships

1257

Number of Boards

20

Birthday

1952

Age

67

Relationships
RelSci Relationships are individuals Arlene Morris likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at Truffle Capital

Relationship likelihood: Strong

Founder at Neovacs SA

Relationship likelihood: Strong

Executive Chairman & Chief Executive Officer at Antyra, Inc.

Relationship likelihood: Strong

Director at Viveve, Inc.

Relationship likelihood: Strong

Executive Chairman at nLife Therapeutics SL

Relationship likelihood: Strong

Former President & Chief Executive Officer at Onyx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Genzyme Corp.

Relationship likelihood: Strong

Co-Founder at Palatin Technologies Inc.

Relationship likelihood: Strong

Professor-Emeritus at University of Pennsylvania

Relationship likelihood: Strong

President & Vice President at Alta Partners III, Inc.

Relationship likelihood: Strong

Paths to Arlene Morris
Potential Connections via
Relationship Science
You
Arlene Morris
Chief Executive Officer at Willow Advisors LLC
Education

THE UNIVERSITY IS A PRIVATE EDUCATIONAL INSTITUTION WHICH AWARDS UNDERGRADUATE, MASTER, AND DOCTORAL DEGREES IN ARTS AND SCIENCES, BUSINESS, ENGINEERING, PHARMACY, AND LAW.

Carlow College

Career History
Chief Executive Officer
2015 - Current

Willow Advisors LLC is a private company headquartered in Berkeley,, that provides consulting services. Arlene M. Morris is the current CEO, occupying that position since 2015.

Chairman, Neovacs, Inc
2015 - Current

Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory and cancerous diseases. It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis and Interferon-Kinoid for treating lupus. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France.

President & Chief Executive Officer
2011 - 2015

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Boards & Committees
Independent Director
2006 - 2013

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Member, Emerging Companies Section Governing Board
Prior - 2015

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Director
Prior

Humane Society of Silicon Valley is an an independent 501(c)(3) non-profit organization located in Milpitas, CA, that has been serving people and pets for over 80 years.

Transactions
Details Hidden

Syndax Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Syndax Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Syndax Pharmaceuticals, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arlene Morris. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arlene Morris's profile does not indicate a business or promotional relationship of any kind between RelSci and Arlene Morris.